{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T14:30:29Z","timestamp":1694356229476},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","prrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.prrv.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T23:48:28Z","timestamp":1406936908000},"page":"167-173","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["New insights into the treatment of severe asthma in children"],"prefix":"10.1016","volume":"16","author":[{"given":"Lisa","family":"Giovannini-Chami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Scheinmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"de Blic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.prrv.2014.07.006_bib0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1398-9995.2008.01672.x","article-title":"Severe asthma in childhood: assessed in 10 year olds in a birth cohort study","volume":"63","author":"Lang","year":"2008","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.prrv.2014.07.006_bib0010","first-page":"405","article-title":"Characterization of the severe asthma phenotype by the National Heart","volume":"119","author":"Moore","year":"2007","journal-title":"Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol."},{"issue":"6","key":"10.1016\/j.prrv.2014.07.006_bib0015","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaci.2006.08.019","article-title":"Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide","volume":"118","author":"Fitzpatrick","year":"2006","journal-title":"J Allergy Clin Immunol."},{"issue":"10","key":"10.1016\/j.prrv.2014.07.006_bib0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/02770900601031540","article-title":"High prevalence of skin test positivity in severe or difficult-to-treat asthma","volume":"43","author":"Haselkorn","year":"2006","journal-title":"J Asthma."},{"issue":"1","key":"10.1016\/j.prrv.2014.07.006_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.02.00232001","article-title":"Costs of asthma are correlated with severity: a 1-yr prospective study","volume":"19","author":"Godard","year":"2002","journal-title":"Eur Respir J."},{"key":"10.1016\/j.prrv.2014.07.006_bib0030","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","author":"Chung","year":"2013","journal-title":"Eur Respir J."},{"issue":"1","key":"10.1016\/j.prrv.2014.07.006_bib0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1183\/09031936.00104809","article-title":"Problematic severe asthma in children, not one problem but many: a GA2LEN initiative","volume":"36","author":"Hedlin","year":"2010","journal-title":"Eur Respir J."},{"issue":"5","key":"10.1016\/j.prrv.2014.07.006_bib0040","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaci.2010.07.019","article-title":"Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma","volume":"126","author":"Bousquet","year":"2010","journal-title":"J Allergy Clin Immunol."},{"issue":"12","key":"10.1016\/j.prrv.2014.07.006_bib0045","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/all.12275","article-title":"EAACI position statement on asthma exacerbations and severe asthma","volume":"68","author":"Custovic","year":"2013","journal-title":"Allergy."},{"issue":"10","key":"10.1016\/j.prrv.2014.07.006_bib0050","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/adc.2008.152140","article-title":"The importance of nurse-led home visits in the assessment of children with problematic asthma","volume":"94","author":"Bracken","year":"2009","journal-title":"Arch Dis Child."},{"issue":"1","key":"10.1016\/j.prrv.2014.07.006_bib0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaci.2011.10.030","article-title":"Adherence to inhaled corticosteroids: an ancillary study of the Childhood Asthma Management Program clinical trial","volume":"129","author":"Krishnan","year":"2012","journal-title":"J Allergy Clin Immunol."},{"issue":"9743","key":"10.1016\/j.prrv.2014.07.006_bib0060","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(10)61054-9","article-title":"Management of severe asthma in children","volume":"376","author":"Bush","year":"2010","journal-title":"Lancet."},{"issue":"2","key":"10.1016\/j.prrv.2014.07.006_bib0065","first-page":"164","article-title":"Hereditary glucocorticoid resistance","volume":"62","author":"Lamberts","year":"2001","journal-title":"Ann Endocrinol (Paris)."},{"issue":"3","key":"10.1016\/j.prrv.2014.07.006_bib0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","article-title":"Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease","volume":"131","author":"Barnes","year":"2013","journal-title":"J Allergy Clin Immunol."},{"issue":"12","key":"10.1016\/j.prrv.2014.07.006_bib0075","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1172\/JCI119874","article-title":"Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing","volume":"100","author":"Martinez","year":"1997","journal-title":"J Clin Invest."},{"issue":"7","key":"10.1016\/j.prrv.2014.07.006_bib0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/FPC.0b013e32832c440e","article-title":"Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma","volume":"19","author":"Corvol","year":"2009","journal-title":"Pharmacogenet Genomics."},{"issue":"9703","key":"10.1016\/j.prrv.2014.07.006_bib0085","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(09)61492-6","article-title":"Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial","volume":"374","author":"Wechsler","year":"2009","journal-title":"Lancet."},{"issue":"11","key":"10.1016\/j.prrv.2014.07.006_bib0090","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa1001278","article-title":"Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids","volume":"362","author":"Lemanske","year":"2010","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1016\/j.prrv.2014.07.006_bib0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.prrv.2011.01.003","article-title":"Phenotypes of refractory\/severe asthma","volume":"12","author":"Bush","year":"2011","journal-title":"Paediatr Respir Rev."},{"issue":"5","key":"10.1016\/j.prrv.2014.07.006_bib0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaci.2013.08.040","article-title":"Glucocorticoid-induced osteoporosis: an update on effects and management","volume":"132","author":"Buehring","year":"2013","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"10.1016\/j.prrv.2014.07.006_bib0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40262-012-0021-x","article-title":"Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate","volume":"52","author":"Allen","year":"2013","journal-title":"Clin Pharmacokinet."},{"issue":"3","key":"10.1016\/j.prrv.2014.07.006_bib0110","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.coph.2010.06.001","article-title":"New asthma drugs: small molecule inhaled corticosteroids","volume":"10","author":"Gentile","year":"2010","journal-title":"Curr Opin Pharmacol."},{"key":"10.1016\/j.prrv.2014.07.006_bib0115","first-page":"CD010352","article-title":"Ciclesonide versus other inhaled corticosteroids for chronic asthma in children","volume":"2","author":"Kramer","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"issue":"12","key":"10.1016\/j.prrv.2014.07.006_bib0120","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.rmed.2010.05.021","article-title":"Difference between patient-reported side effects of ciclesonide versus fluticasone propionate","volume":"104","author":"van der Molen","year":"2010","journal-title":"Respir Med."},{"issue":"3","key":"10.1016\/j.prrv.2014.07.006_bib0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.pupt.2007.11.002","article-title":"Randomized comparison of ciclesonide 160 and 640 microg\/day in severe asthma","volume":"21","author":"Bateman","year":"2008","journal-title":"Pulm Pharmacol Ther."},{"issue":"8","key":"10.1016\/j.prrv.2014.07.006_bib0130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1513\/pats.200907-071DP","article-title":"Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease","volume":"6","author":"Barnes","year":"2009","journal-title":"Proc Am Thorac Soc."},{"issue":"1","key":"10.1016\/j.prrv.2014.07.006_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.2010.01199.x","article-title":"Glucocorticosteroids: current and future directions","volume":"163","author":"Barnes","year":"2011","journal-title":"Br J Pharmacol."},{"issue":"1","key":"10.1016\/j.prrv.2014.07.006_bib0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/thoraxjnl-2012-202482","article-title":"Tiotropium Respimat increases the risk of mortality","volume":"68","author":"Jenkins","year":"2013","journal-title":"Thorax."},{"issue":"5","key":"10.1016\/j.prrv.2014.07.006_bib0145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1056\/NEJMc1314411","article-title":"Tiotropium and the risk of death in COPD","volume":"370","author":"Loke","year":"2014","journal-title":"N Engl J Med."},{"issue":"13","key":"10.1016\/j.prrv.2014.07.006_bib0150","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med."},{"issue":"18","key":"10.1016\/j.prrv.2014.07.006_bib0155","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.prrv.2014.07.006_bib0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.00065111","article-title":"Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells","volume":"40","author":"Yamaya","year":"2012","journal-title":"Eur Respir J."},{"issue":"11","key":"10.1016\/j.prrv.2014.07.006_bib0165","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.rmed.2010.06.011","article-title":"24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: a comparison with placebo and salmeterol","volume":"104","author":"Sugihara","year":"2010","journal-title":"Respir Med."},{"issue":"24","key":"10.1016\/j.prrv.2014.07.006_bib0170","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMp1109621","article-title":"The risks and benefits of indacaterol--the FDA's review","volume":"365","author":"Chowdhury","year":"2011","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.prrv.2014.07.006_bib0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/thoraxjnl-2012-202606","article-title":"Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the beta2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial","volume":"68","author":"Busse","year":"2013","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.prrv.2014.07.006_bib0180","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1378\/chest.13-0178","article-title":"Efficacy and safety of fluticasone furoate\/vilanterol compared with fluticasone propionate\/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial","volume":"144","author":"Woodcock","year":"2013","journal-title":"Chest."},{"key":"10.1016\/j.prrv.2014.07.006_bib0185","doi-asserted-by":"crossref","unstructured":"Bateman ED, O\u2019Byrne PM, Busse WW, Lotvall J, Bleecker ER, Andersen L, et al. Once-daily fluticasone furoate (FF)\/vilanterol reduces risk of severe exacerbations in asthma versus FF alone. Thorax. 2013 Nov 19.","DOI":"10.1136\/thoraxjnl-2013-203600"},{"key":"10.1016\/j.prrv.2014.07.006_bib0190","article-title":"Bronchodilation with mometasone furoate\/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma","author":"Berger","year":"2013","journal-title":"Pediatr Pulmonol."},{"issue":"4","key":"10.1016\/j.prrv.2014.07.006_bib0195","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.00095906","article-title":"Beclomethasone\/formoterol versus budesonide\/formoterol combination therapy in asthma","volume":"29","author":"Papi","year":"2007","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.prrv.2014.07.006_bib0200","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1398-9995.2007.01493.x","article-title":"Beclomethasone\/formoterol vs fluticasone\/salmeterol inhaled combination in moderate to severe asthma","volume":"62","author":"Papi","year":"2007","journal-title":"Allergy."},{"issue":"5","key":"10.1016\/j.prrv.2014.07.006_bib0205","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1183\/09031936.00070511","article-title":"Distinct epithelial gene expression phenotypes in childhood respiratory allergy","volume":"39","author":"Giovannini-Chami","year":"2012","journal-title":"Eur Respir J."},{"issue":"5397","key":"10.1016\/j.prrv.2014.07.006_bib0210","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","article-title":"Requirement for IL-13 independently of IL-4 in experimental asthma","volume":"282","author":"Grunig","year":"1998","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.prrv.2014.07.006_bib0215","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1016\/j.prrv.2014.07.006_bib0220","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1183\/09031936.00149812","article-title":"Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey","volume":"42","author":"Deschildre","year":"2013","journal-title":"Eur Respir J."},{"issue":"11","key":"10.1016\/j.prrv.2014.07.006_bib0225","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am J Respir Crit Care Med."},{"issue":"10","key":"10.1016\/j.prrv.2014.07.006_bib0230","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.prrv.2014.07.006_bib0235","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med."},{"issue":"9842","key":"10.1016\/j.prrv.2014.07.006_bib0240","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.prrv.2014.07.006_bib0245","doi-asserted-by":"crossref","first-page":"14170","DOI":"10.1073\/pnas.1009426107","article-title":"Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma","volume":"107","author":"Sidhu","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"40","key":"10.1016\/j.prrv.2014.07.006_bib0250","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"10.1016\/j.prrv.2014.07.006_bib0255","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1172\/JCI58978","article-title":"Periostin promotes chronic allergic inflammation in response to Th2 cytokines","volume":"122","author":"Masuoka","year":"2012","journal-title":"J Clin Invest."},{"issue":"5","key":"10.1016\/j.prrv.2014.07.006_bib0260","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"issue":"12","key":"10.1016\/j.prrv.2014.07.006_bib0265","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.prrv.2014.07.006_bib0270","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1183\/09031936.00223411","article-title":"A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma","volume":"41","author":"Piper","year":"2013","journal-title":"Eur Respir J."},{"issue":"8","key":"10.1016\/j.prrv.2014.07.006_bib0275","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1164\/rccm.201008-1210OC","article-title":"Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma","volume":"183","author":"Gauvreau","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"10.1016\/j.prrv.2014.07.006_bib0280","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2014.01.002","article-title":"Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trial","volume":"133","author":"De Boever","year":"2014","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"10.1016\/j.prrv.2014.07.006_bib0285","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1164\/ajrccm.160.6.9808146","article-title":"Interleukin-4 receptor in moderate atopic asthma. A phase I\/II randomized, placebo-controlled trial","volume":"160","author":"Borish","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"issue":"6","key":"10.1016\/j.prrv.2014.07.006_bib0290","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1067\/mai.2001.115624","article-title":"Efficacy of soluble IL-4 receptor for the treatment of adults with asthma","volume":"107","author":"Borish","year":"2001","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"10.1016\/j.prrv.2014.07.006_bib0295","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.iac.2004.06.008","article-title":"Anti-interleukin-4 therapy","volume":"24","author":"Steinke","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"issue":"9","key":"10.1016\/j.prrv.2014.07.006_bib0300","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/0091270009341183","article-title":"Human pharmacokinetics\/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma","volume":"49","author":"Burmeister Getz","year":"2009","journal-title":"J Clin Pharmacol."},{"issue":"9596","key":"10.1016\/j.prrv.2014.07.006_bib0305","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(07)61600-6","article-title":"Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies","volume":"370","author":"Wenzel","year":"2007","journal-title":"Lancet."},{"issue":"2","key":"10.1016\/j.prrv.2014.07.006_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.03.030","article-title":"IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor alpha antagonist","volume":"130","author":"Slager","year":"2012","journal-title":"J Allergy Clin Immunol."},{"issue":"8","key":"10.1016\/j.prrv.2014.07.006_bib0315","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.200909-1448OC","article-title":"A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma","volume":"181","author":"Corren","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"26","key":"10.1016\/j.prrv.2014.07.006_bib0320","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.prrv.2014.07.006_bib0325","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2466-11-14","article-title":"Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma","volume":"11","author":"Parker","year":"2011","journal-title":"BMC Pulm Med."},{"issue":"22","key":"10.1016\/j.prrv.2014.07.006_bib0330","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.prrv.2014.07.006_bib0335","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus","volume":"201","author":"Wark","year":"2005","journal-title":"J Exp Med."},{"issue":"9","key":"10.1016\/j.prrv.2014.07.006_bib0340","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat Med."},{"issue":"4","key":"10.1016\/j.prrv.2014.07.006_bib0345","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mi.2012.118","article-title":"Impaired innate interferon induction in severe therapy resistant atopic asthmatic children","volume":"6","author":"Edwards","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.prrv.2014.07.006_bib0350","article-title":"Rhinovirus-induced interferon production is not deficient in well controlled asthma","author":"Sykes","year":"2013","journal-title":"Thorax."},{"issue":"4","key":"10.1016\/j.prrv.2014.07.006_bib0355","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax."},{"issue":"8","key":"10.1016\/j.prrv.2014.07.006_bib0360","doi-asserted-by":"crossref","first-page":"e1003520","DOI":"10.1371\/journal.ppat.1003520","article-title":"An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation","volume":"9","author":"Traub","year":"2013","journal-title":"PLoS Pathog."},{"issue":"19","key":"10.1016\/j.prrv.2014.07.006_bib0365","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1211917","article-title":"Respiratory syncytial virus and recurrent wheeze in healthy preterm infants","volume":"368","author":"Blanken","year":"2013","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.prrv.2014.07.006_bib0370","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jaci.2013.06.006","article-title":"Viral infection of the lung: host response and sequelae","volume":"132","author":"Yoo","year":"2013","journal-title":"J Allergy Clin Immunol."},{"issue":"7","key":"10.1016\/j.prrv.2014.07.006_bib0375","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1164\/rccm.201105-0883CI","article-title":"Bronchial thermoplasty for severe asthma","volume":"185","author":"Wahidi","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"issue":"1","key":"10.1016\/j.prrv.2014.07.006_bib0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1183\/09031936.00123411","article-title":"Two novel, severe asthma phenotypes identified during childhood using a clustering approach","volume":"40","author":"Just","year":"2012","journal-title":"Eur Respir J."},{"issue":"2","key":"10.1016\/j.prrv.2014.07.006_bib0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.11.015","article-title":"Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health\/National Heart, Lung, and Blood Institute Severe Asthma Research Program","volume":"127","author":"Fitzpatrick","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.prrv.2014.07.006_bib0390","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00220413","article-title":"The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia","author":"Ortega","year":"2014","journal-title":"Eur Respir J."},{"issue":"12","key":"10.1016\/j.prrv.2014.07.006_bib0395","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/all.12312","article-title":"Mechanisms and potential therapeutic targets in allergic inflammation: recent insights","volume":"68","author":"von Gunten","year":"2013","journal-title":"Allergy."},{"issue":"9","key":"10.1016\/j.prrv.2014.07.006_bib0400","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/thoraxjnl-2011-201262","article-title":"Genome-wide association study to identify genetic determinants of severe asthma","volume":"67","author":"Wan","year":"2012","journal-title":"Thorax."}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054214000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054214000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T13:38:47Z","timestamp":1565703527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054214000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1526054214000840"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2014.07.006","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into the treatment of severe asthma in children","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}